Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trial

Goebeler M. and Csörgő Sándorné Bata Zsuzsanna and De Simone C. and Didona B. and Remenyik Éva and Reznichenko N. and Stoevesandt J. and Ward E. S. and Parys W. and de Haard H. and Dupuy P. and Verheesen P. and Schmidt E. and Joly P. and Kollaborációs szervezet: ARGX-113-1701 Investigator Study Group (kollab. közrem.): Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trial.
BRITISH JOURNAL OF DERMATOLOGY, 186 (3). pp. 429-439. ISSN 0007-0963 (2022)

[thumbnail of bjd0429.pdf]
Preview
Text
bjd0429.pdf - Published Version

Download (324kB) | Preview
Item Type: Journal Article
Journal or Publication Title: BRITISH JOURNAL OF DERMATOLOGY
Date: 2022
Volume: 186
Number: 3
Page Range: pp. 429-439
ISSN: 0007-0963
Faculty/Unit: Albert Szent-Györgyi Medical School
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 32604600
DOI azonosító: https://doi.org/10.1111/bjd.20782
Date Deposited: 2023. Feb. 20. 10:05
Last Modified: 2023. Feb. 20. 10:05
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/26532
Web of Science® Times Cited: 43 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year